acetaminophen has been researched along with tetraethylammonium in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Alloui, A; Boudes, M; Bourinet, E; Chemin, J; Eschalier, A; François, A; Kerckhove, N; Mallet, C; Voets, T | 1 |
2 other study(ies) available for acetaminophen and tetraethylammonium
Article | Year |
---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Ca(v)3.2 calcium channels: the key protagonist in the supraspinal effect of paracetamol.
Topics: 4-Aminopyridine; Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Arthritis; Calcium Channels, T-Type; Cells, Cultured; Drug Administration Routes; Drug Interactions; Ganglia, Spinal; Humans; Male; Membrane Potentials; Mice; Mice, Knockout; Morphine; Neurons; Pain Measurement; Potassium Channel Blockers; Spinal Cord; Tetraethylammonium; TRPV Cation Channels | 2014 |